NCT05022511 is a NA clinical trial of Screening status in Uterine Cervical Cancer, sponsored by University of Aarhus.

Who is sponsoring NCT05022511?

NCT05022511 is sponsored by University of Aarhus.

What drugs are being tested in NCT05022511?

Interventions in NCT05022511: Screening status.

What condition does NCT05022511 study?

NCT05022511 studies Uterine Cervical Cancer, Uterine Cervix Cancer, Uterine Cervical Neoplasm, Colorectal Neoplasms, Colorectal Cancer, Colorectal Carcinoma, Mass Screening, Early Detection of Cancer.

Is NCT05022511 still recruiting?

NCT05022511 is currently completed. Last updated 18 November 2023.

Last reviewed 2023-11-18 · How we verify

NCT05022511

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Three Birds With One Stone

Completed NA Last updated 18 November 2023

What this trial tests

NA trial testing Screening status in Uterine Cervical Cancer in 27,099 participants. Completed in 1 September 2023.

Timeline

1 September 2021

Primary endpoint
1 December 2022

1 September 2023

Quick facts

Lead sponsor	University of Aarhus
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	27,099
Start date	1 September 2021
Primary completion	1 December 2022
Estimated completion	1 September 2023
Sites	1 location across Denmark

Drugs / interventions tested

Screening status

Conditions studied

Uterine Cervical Cancer — all drugs for Uterine Cervical Cancer →
Uterine Cervix Cancer — all drugs for Uterine Cervix Cancer →
Uterine Cervical Neoplasm — all drugs for Uterine Cervical Neoplasm →
Colorectal Neoplasms — all drugs for Colorectal Neoplasms →

Sponsor

University of Aarhus

Who can join

Adults 50 to 69, female only, with Uterine Cervical Cancer or Uterine Cervix Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall aim of the study is to increase participation rates in cervical cancer (CCU) and colorectal cancer (CRC) screening programmes in Denmark by offering home-based CCU and CRC screening to women who are overdue for one or both screening programmes when attending breast cancer screening

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Concurrent participation in breast, cervical, and colorectal cancer screening programmes in Denmark: A nationwide registry-based study.
Njor SH, Søborg B, Tranberg M, Rebolj M. · · 2023 · cited 10× · PMID 36581010 · DOI 10.1016/j.ypmed.2022.107405
Increasing coverage in cervical and colorectal cancer screening by leveraging attendance at breast cancer screening: A cluster-randomised, crossover trial.
Helgestad ADL, Larsen MB, Njor S, Tranberg M, et al · · 2024 · cited 5× · PMID 39137185 · DOI 10.1371/journal.pmed.1004431
Three birds with one stone: a protocol for a randomised intervention study to increase participation in cervical and colorectal cancer screening among women attending breast cancer screening.
Helgestad ADL, Larsen MB, Njor S, Tranberg M, et al · · 2022 · cited 3× · PMID 36137619 · DOI 10.1136/bmjopen-2022-062824

Verify or expand the search:

Other recruiting trials for Uterine Cervical Cancer

Currently open trials in the same condition.

NCT04516616 — Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer · Phase 2 · active not recruiting
NCT04857528 — Detecting HPV DNA in Anal and Cervical Cancers · recruiting

Other University of Aarhus trials

Trials by the same sponsor.

NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05022511 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
Last refreshed: 18 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05022511.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing